Project Description

Patients Breathe Easier with New Generic Advair Option

Client: Hikma Pharmaceuticals

The Challenge:

With the thumbs up from the FDA, Hikma Pharmaceuticals launched its generic version of GlaxoSmithKline’s Advair Diskus®. Responsory worked briskly behind the scenes to help the multinational pharmaceutical company create a brand identity, collateral and website where patients can find product info and instructions for using the inhaler.

Client: Avicena

The Solution:

One of our priorities was to tout how the active ingredients in Advair Diskus® and Hikma’s generic Fluticasone Propionate and Salmeterol Inhalation Powder, USP are the same. The noticeable difference for patients is the inhaler device. Hikma worked with Vectura Group to develop the proprietary dry powder inhaler and formulation technology.

Responsory designed a companion “Instructions for Use” guide to educate patients on how to effectively administer the medication.

The Result:

Responsory is proud to be a part of another swift and successful Hikma generic drug launch.